Jan Nilsson

Professor, överläkare
Fler filtreringsmöjligheter
  1. 2009
  2. Regulatory T cells and the control of modified lipoprotein autoimmunity-driven atherosclerosis.

    Jan Nilsson, Maria Wigren & Shah, P. K., 2009, I : Trends in Cardiovascular Medicine. 19, 8, s. 272-276

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Shifting to new targets in pharmacological prevention of cardiovascular diseases

    Jan Nilsson & Kovanen, P. T., 2009, I : Current Opinion in Lipidology. 20, 5, s. 361-362

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  4. Tumor necrosis factor-alpha does not mediate diabetes-induced vascular inflammation in mice.

    Öhman, J., Nordin Fredrikson, G., Lisa Berglund, Gustavsson, C., Eva Bengtsson, Smith, M-L., Agardh, C-D., Elisabet Agardh, Jovinge, S., Maria Gomez & Jan Nilsson, 2009, I : Arteriosclerosis, Thrombosis and Vascular Biology. 29, 10, s. 1465-1470

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Vaccination against atherosclerosis? Induction of atheroprotective immunity

    Hansson, G. K. & Jan Nilsson, 2009, I : Seminars in Immunopathology. 31, 1, s. 95-101

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  6. Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease.

    Jan Nilsson, Nordin Fredrikson, G., Harry Björkbacka, Chyu, K-Y. & Shah, P. K., 2009, I : Journal of Internal Medicine. 266, 3, s. 221-231

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. 2008
  8. Athero-protective effects of a human apoB-100 related peptide vaccine in apoE-/- mice are modulated by peptide dose and time of initiation of high fat diet

    Zhao, X., Chyu, K-Y., Yano, J., Dimayuga, P. C., Li, X., Trinidad, P., Jovicic, S., Cercek, B., Jan Nilsson & Shah, P. K., 2008, I : Journal of the American College of Cardiology. 51, 10, Suppl. 1, s. A343-A343

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  9. Autoantibodies against modified apolipoprotein B-100 in relation to low-density lipoprotein size and the metabolic syndrome in otherwise healthy men

    Sjögren, P., Nordin Fredrikson, G., Rosell, M., de Faire, U., Hamsten, A., Jan Nilsson, Hellenius, M-L. & Fisher, R. M., 2008, I : Metabolism, Clinical and Experimental. 57, 3, s. 362-366

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Cystatin C and cathepsins in cardiovascular disease.

    Eva Bengtsson, Jan Nilsson & Jovinge, S., 2008, I : Frontiers in Bioscience. 13, 1, s. 5780-5786

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Evaluation of the T cell response to apolipoprotein B100 (ApoB100): A new opportunity for immunotherapy against atherosclerosis

    Ketelhuth, D. F. J., Hermansson, A., Wurm, M., Tornberg, I., Strodthoff, D., Nordin Fredrikson, G., Jan Nilsson & Hansson, G., 2008, I : Scandinavian Journal of Immunology. 68, 2, s. 244-245

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  12. High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction

    Sjogren, P., Nordin Fredrikson, G., Samnegard, A., Ericsson, C-G., Ohrvik, J., Fisher, R. M., Jan Nilsson & Hamsten, A., 2008, I : European Heart Journal. 29, 18, s. 2218-2226

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. Inflammation and immunity in diabetic vascular complications.

    Jan Nilsson, Eva Bengtsson, Nordin Fredrikson, G. & Harry Björkbacka, 2008, I : Current Opinion in Lipidology. 19, 5, s. 519-524

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. Interleukin-1 beta and tumour necrosis factor-alpha impede neutral lipid turnover in macrophage-derived foam cells

    Persson, J., Jan Nilsson & Lindholm, M., 2008, I : BMC Immunology. 9, 70.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. 2007
  16. Active and passive immunization for atherosclerosis

    Chyu, K-Y., Jan Nilsson & Shah, P. K., 2007, I : Current Opinion in Molecular Therapeutics. 9, 2, s. 176-182

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  17. Association between IgM against an aldehyde-modified peptide in apolipoprotein B-100 and progression of carotid disease

    Nordin Fredrikson, G., Bo Hedblad, Berglund, G., Alm, R., Nilsson, J-Å., Alexandru Schiopu, Shah, P. K. & Jan Nilsson, 2007, I : Stroke: a journal of cerebral circulation. 38, 5, s. 1495-1500

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Autoantibody against the amino acid sequence 661-680 in apo B-100 is associated with decreased carotid stenosis and cardiovascular events.

    Nordin Fredrikson, G., Alexandru Schiopu, Berglund, G., Alm, R., Shah, P. K. & Jan Nilsson, 2007, I : Atherosclerosis.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. Autoimmune responses against the apo B-100 LDL receptor-binding site protect against arterial accumulation of lipids in LDL receptor deficient mice.

    Nordin Fredrikson, G., Lindholm, M., Ljungcrantz, I., Söderberg, I., Shah, P. K. & Jan Nilsson, 2007, I : Autoimmunity. 40, 2, s. 122-130

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Immunization for atherosclerosis

    Chyu, K-Y., Jan Nilsson & Shah, P. K., 2007, I : Current Atherosclerosis Reports. 9, 2, s. 104-109

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  21. Immunomodulation of atherosclerosis

    Jan Nilsson, Nordin Fredrikson, G., Alexandru Schiopu, Isabel Goncalves, Chyu, KY. & Shah, P. K., 2007, The Vulnerable Plaque. Waksman, R., Serruys, PW. & Schaar, J. (red.). 2 uppl. London: Informa Healthcare, s. 371-382

    Forskningsoutput: Kapitel i bok/rapport/Conference proceedingKapitel samlingsverk

  22. Inhibition of injury-induced arterial remodelling and carotid atherosclerosis by recombinant human antibodies against aldehyde-modified apoB-100.

    Ström, Å., Nordin Fredrikson, G., Alexandru Schiopu, Ljungcrantz, I., Söderberg, I., Jansson, B., Carlsson, R., Anna Hultgårdh & Jan Nilsson, 2007, I : Atherosclerosis. 190, 2, s. 298-305

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. Involvement of the CD1d-Natural killer T cell pathway in neointima formation after vascular injury

    Ström, Å., Maria Wigren, Anna Hultgårdh, Saxena, A., Maria Gomez, Cardell, S., Nordin Fredrikson, G. & Jan Nilsson, 2007, I : Circulation Research. 101, 8, s. E83-E89

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Medial Expression of TNF-α and TNF Receptors Precedes the Development of Atherosclerotic Lesions in Apolipoprotein E/LDL Receptor Double Knockout Mice

    Niemann-Jönsson, A., Söderberg, I., Lindholm, M., Jovinge, S., Jan Nilsson & Nordin Fredrikson, G., 2007, I : International Journal of Biomedical Science. 3, 2, s. 117-123

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. Oxidized LDL antibodies in treatment and risk assessment of atherosclerosis and associated cardiovascular disease.

    Jan Nilsson, Nordin Fredrikson, G., Alexandru Schiopu, Shah, P. K., Bo Jansson & Carlsson, R., 2007, I : Current Pharmaceutical Design. 13, 10, s. 1021-1030

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  26. Perilipin and adipophilin expression in lipid loaded macrophages

    Persson, J., Eva Degerman, Jan Nilsson & Lindholm, M., 2007, I : Biochemical and Biophysical Research Communications. 363, 4, s. 1020-1026

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice.

    Alexandru Schiopu, Frendéus, B., Jansson, B., Söderberg, I., Ljungcrantz, I., Araya, Z., Shah, P. K., Carlsson, R., Jan Nilsson & Nordin Fredrikson, G., 2007, I : Journal of the American College of Cardiology. 50, 24, s. 2313-2318

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. Simvastatin stimulates macrophage interleukin-1beta secretion through an isoprenylation-dependent mechanism.

    Lindholm, M. & Jan Nilsson, 2007, I : Vascular Pharmacology. 46, Jul 25, s. 91-96

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. VLDL and atherosclerosis

    Jan Nilsson, Ares, M. P. S. & Dichtl, W., 2007, Endothelial dysfunction and vascular disease. Libby, P. & Caterina, P. (red.). Wiley-Blackwell

    Forskningsoutput: Kapitel i bok/rapport/Conference proceedingKapitel samlingsverk

  30. 2006
  31. Antibodies against oxidized low-density lipoprotein for the treatment of vulnerable plaques

    Jan Nilsson, Glaser, S. & Carlsson, R., 2006, I : Current Opinion in Investigational Drugs. 7, 815.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. Cytokine response to lipoprotein lipid loading in human monocyte-derived macrophages

    Persson, J., Jan Nilsson & Lindholm, M., 2006, I : Lipids in Health and Disease. 5, 17

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. Identification of autoantibodies in human plasma recognizing an apoB-100 LDL receptor binding site peptide

    Nordin Fredrikson, G., Berglund, G., Alm, R., Nilsson, J-Å., Shah, P. K. & Jan Nilsson, 2006, I : Journal of Lipid Research. 47, 9, s. 2049-2054

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. Oxidants and antioxidants

    Jan Nilsson, 2006, Risk factors in coronary artery disease. Shah, P. K. (red.). Taylor & Francis, s. 199

    Forskningsoutput: Kapitel i bok/rapport/Conference proceedingKapitel samlingsverk

  35. Oxidized lipoprotein autoimmunity: an emerging drug target in cardiovascular disease

    Jan Nilsson, Nordin Fredrikson, G., Chyu, K-Y., Shah, P. K. & Harry Björkbacka, 2006, I : Future Lipidology. 1, 3, s. 321-330

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  36. 2005
  37. Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice.

    Eva Bengtsson, To, F., Anders Grubb, Håkansson, K., Wittgren, L., Jan Nilsson & Jovinge, S., 2005, I : Atherosclerosis. 180, 1, s. 45-53

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression.

    Nordin Fredrikson, G., Andersson, L., Söderberg, I., Dimayuga, P., Chyu, K-Y., Shah, P. K. & Jan Nilsson, 2005, I : Autoimmunity. 38, 2, s. 171-179

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. CRP - Marker or maker of cardiovascular disease?

    Jan Nilsson, 2005, I : Arteriosclerosis, Thrombosis and Vascular Biology. 25, 8, s. 1527-1528

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  40. Humoral Immune Response Against Defined Oxidized Low-Density Lipoprotein Antigens Reflects Structure and Disease Activity of Carotid Plaques.

    Isabel Goncalves, Gronholdt, M-L. M., Söderberg, I., Ares, M., Nordestgaard, B. G., Bentzon, J. F., Nordin Fredrikson, G. & Jan Nilsson, 2005, I : Arteriosclerosis, Thrombosis and Vascular Biology. 25, 6, s. 1250-1255

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  41. Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E(-/-) mice

    Chyu, KY., Zhao, XN., Reyes, OS., Babbidge, SM., Dimayuga, PC., Yano, J., Cercek, B., Nordin Fredrikson, G., Jan Nilsson & Shah, PK., 2005, I : Biochemical and Biophysical Research Communications. 338, 4, s. 1982-1989

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. Immunomodulation of Atherosclerosis. Implications for Vaccine Development.

    Jan Nilsson, Hansson, G. K. & Shah, P. K., 2005, I : Arteriosclerosis, Thrombosis and Vascular Biology. 25, 1, s. 18-28

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  43. Immunomodulation of atherosclerosis with a vaccine

    Shah, PK., Chyu, KY., Fredrikson, G. & Jan Nilsson, 2005, I : Nature Clinical Practice Cardiovascular Medicine. 2, 12, s. 639-646

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  44. Kan man hitta instabila karotisplack med ultraljud?

    Isabel Goncalves, Jan Nilsson & Ares, M., 2005, I : Kärilet. 17, 4, s. 4-6

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  45. Lack of the Cysteine-Protease Inhibitor Cystatin C Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice.

    Eva Bengtsson, To, F., Håkansson, K., Anders Grubb, Brånén, L., Jan Nilsson & Jovinge, S., 2005, I : Arteriosclerosis, Thrombosis and Vascular Biology. 25, 10, s. 2151-2156

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. Low density lipoprotein stimulation of human macrophage proteoglycan secretion.

    Lindholm, M., Jan Nilsson & Moses, J., 2005, I : Biochemical and Biophysical Research Communications. 328, 2, s. 455-460

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  47. Regulating protective immunity in atherosclerosis

    Jan Nilsson, 2005, I : Circulation Research. 96, 4, s. 395-397

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  48. T Cell Modulation of Intimal Thickening After Vascular Injury. The Bimodal Role of IFN-{gamma} in Immune Deficiency.

    Dimayuga, P. C., Li, H., Chyu, K-Y., Nordin Fredrikson, G., Jan Nilsson, Fishbein, M. C., Shah, P. K. & Cercek, B., 2005, I : Arteriosclerosis, Thrombosis and Vascular Biology. 25, Oct 13, s. 2528-2534

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  49. Very low-density lipoprotein induces interleukin-1beta expression in macrophages.

    Stollenwerk, M., Lindholm, M., Ares, I., Larsson, A., Jan Nilsson & Ares, M., 2005, I : Biochemical and Biophysical Research Communications. 335, 2, s. 603-608

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  50. Very low density lipoprotein potentiates tumor necrosis factor-alpha expression in macrophages.

    Stollenwerk, M., Alexandru Schiopu, Nordin Fredrikson, G., Dichtl, W., Jan Nilsson & Ares, M., 2005, I : Atherosclerosis. 179, 2, s. 247-254

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  51. 2004
  52. Altered AP-1/Ref-1 redox pathway and reduced proliferative response in iNOS-deficient vascular smooth muscle cells

    Chyu, KY., Dimayuga, PC., Zhao, XN., Jan Nilsson, Shah, PK. & Cercek, B., 2004, I : Vascular Medicine. 9, 3, s. 177-183

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  53. Association between diet, lifestyle, metabolic cardiovascular risk factors, and plasma C-reactive protein levels.

    Nordin Fredrikson, G., Bo Hedblad, Alm, R., Berglund, G. & Jan Nilsson, 2004, I : Metabolism, Clinical and Experimental. 53, 11, s. 1436-1442

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  54. Atherosclerosis.

    Jan Nilsson & Nordin Fredrikson, G., 2004, I : Autoimmunity. 37, 4, s. 351-355

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  55. Elastin and calcium rather than collagen or lipid content are associated with echogenicity of human carotid plaques.

    Isabel Goncalves, Lindholm, M., Pedro, L. M., Nuno Dias, Fernandes e Fernandes, J., Nordin Fredrikson, G., Jan Nilsson, Moses, J. & Ares, M., 2004, I : Stroke: a journal of cerebral circulation. 35, 12, s. 2795-2800

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift